Academy of Military Medical Sciences, Beijing, China.
Institute for Disease Control and Prevention of PLA, Beijing, China.
Sci Rep. 2018 Jul 13;8(1):10653. doi: 10.1038/s41598-018-28879-9.
The emergence of carbapenemase-producing Citrobacter freundii poses a significant threat to public health worldwide. Here, we reported a C. freundii strain CWH001 which was resistant to all tested antimicrobials except tetracycline. Whole genome sequencing and analysis were performed. The strain, which belonged to a new sequence type ST139, showed close relationship with other foreign C. freundii strains through phylogenetic analysis. A novel variant of the intrinsic bla gene located on the chromosome was identified and designated as bla. Coexistence of bla with qnrS1 was found on a conjugative IncN plasmid, which had a backbone appearing in various plasmids. Other class A ESBL genes (bla and bla) were also detected on two different novel plasmids. The emergence of multidrug-resistant C. freundii is of major concern, causing great challenges to the treatment of clinical infections. Great efforts need to be taken for the specific surveillance of this opportunistic pathogen.
产碳青霉烯酶弗氏柠檬酸杆菌的出现对全球公共健康构成了重大威胁。在这里,我们报道了一株对除四环素以外的所有测试抗菌药物均具有耐药性的弗氏柠檬酸杆菌菌株 CWH001。进行了全基因组测序和分析。该菌株属于一个新的序列型 ST139,通过系统发育分析显示与其他国外弗氏柠檬酸杆菌菌株密切相关。在染色体上发现了一个位于固有 bla 基因的新型变异体,并将其命名为 bla。bla 与 qnrS1 共存于一个可接合的 IncN 质粒上,该质粒的骨架出现在各种质粒中。在两个不同的新型质粒上还检测到其他 A 类 ESBL 基因(bla 和 bla)。多药耐药性弗氏柠檬酸杆菌的出现令人高度关注,对临床感染的治疗带来了巨大挑战。需要对这种机会性病原体进行具体的监测。